Published: May 15th 2024 | Updated: May 20th 2024
Minimizing the carbon footprint of ophthalmic surgeries
Published: December 16th 2024 | Updated: December 21st 2024
Atsena Therapeutics completes dosing in Part A of phase I/II clinical trial evaluating ATSN-201 to treat X-linked retinoschisis
Published: December 14th 2024 | Updated: December 14th 2024
Study links lower socioeconomic status to increased risk of open globe injury and poorer outcomes
Published: December 13th 2024 | Updated: December 21st 2024
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Published: December 9th 2024 | Updated: December 21st 2024
New study highlights retinopathy risk from hair dye use
Published: December 7th 2024 | Updated: December 21st 2024
FLORetina ICOOR 2024: Charles Wykoff, MD, PhD, discusses diabetic retinopathy and reperfusion